BRCA2 and breast carcinoma: However, the associations differed by the predicted effect of the gene variant on protein stability/expression: the HRs for the PRS associations with breast cancer risk were larger for carriers with class II (stable mutant proteins) versus class I (unstable/no protein) variants (Table 2, BRCA1: class I HR = 1.26 [95% CI = 1.22–1.30], class II HR = 1.38 [1.30–1.46], Pdifference = 0.011; BRCA2: class I HR = 1.30 [95% CI = 1.25–1.35], class II HR = 1.72 [95% CI = 1.44–2.06], Pdifference = 0.003).